Lin J.Ou H.-Y.LEE-MING CHUANGChiu K.C.2020-06-012020-06-0120160270-9139https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975730896&doi=10.1002%2fhep.28399&partnerID=40&md5=44f8a49dcc4b5a55cb70c35bb35d8c8bhttps://scholars.lib.ntu.edu.tw/handle/123456789/495646[SDGs]SDG3glucose; hepatitis B core antibody; hepatitis B surface antigen; hepatitis B vaccine; hepatitis B vaccine; diabetes mellitus; disease association; glucose blood level; hepatitis B; human; infection prevention; Letter; medical history; prevalence; priority journal; risk reduction; vaccination; hepatitis B; insulin dependent diabetes mellitus; Diabetes Mellitus, Type 1; Hepatitis B; Hepatitis B Vaccines; Humansletter10.1002/hep.28399266605112-s2.0-84975730896